Browsing "Endocrinology & Metabolism" by Publication Year :

Jump to a point in the index:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 50 of 614

Pub YearTitleAJOU Author(s)
2024A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)김혜진
2024HDAC11 Regulates Palmitate-induced NLRP3 Inflammasome Activation by Inducing YAP Expression in THP-1 Cells and PBMCs모정순, 변혜은, 전자영, 최성이
2024Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus이관우
2024Higher HbA1c Is Associated With Greater 2-Year Progression of White Matter Hyperintensities노현웅, 문소영, 박범희, 손상준, 안영실, 정재연, 조용혁, 최진욱, 한승진, 홍창형
2024Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations김대중, 하경화
2024Imeglimin attenuates NLRP3 inflammasome activation by restoring mitochondrial functions in macrophages김대중, 김혜진, 이관우, 전자영, 한승진
2024Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study김대중, 하경화
2024Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study김혜진
2024Efficacy and Safety of Metformin and AtorvastatinCombination Therapy vs. Monotherapy with EitherDrug in Type 2 Diabetes Mellitus and DyslipidemiaPatients (ATOMIC): Double-Blinded RandomizedControlled Trial김대중
2024The Association of Smoking Status with Diabetic Microvascular Complications in Korean Patients with Type 2 Diabetes이관우
2024Comparative effectiveness and safety outcomes between denosumab and bisphosphonate in South Korea박래웅, 전자영
2024Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
20242023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association김대중, 김혜진
2024Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease김대중, 하경화
2024Acute Suppurative Thyroiditis as a Presentation of Disseminated Methicillin-Resistant Staphylococcus aureus Infection in an Adult with Type 1 Diabetes이나미, 전자영, 최용준, 한승진
2024Cancer treatment-induced bone loss최용준
2024Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus김대중, 전자영
2024Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study한승진
2023Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study김대중, 하경화
2023Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes김대중, 하경화
2023Asia–pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures정윤석
2023Ultra-Processed Food Consumption and Obesity in Korean Adults김대중, 하경화
2023Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study김대중, 하경화, 한승진
2023Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia김대중, 하경화
2023Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study김영롱, 김은진, 유진세, 최영화, 하경화, 허중연
2023Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus김혜진
2023Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators김대중, 하경화
2023Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea김대중, 하경화
2023Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study김혜진
2023Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients김대중, 김혜진, 박범희, 이관우, 전자영, 한승진
2023Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study김대중, 하경화
2023Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study이관우
2023In-depth proteomic signature of parathyroid carcinoma최용준
2023Changes in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study방준배, 오창권, 이수형, 전자영
2023Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study김대중
2023UBAP2 plays a role in bone homeostasis through the regulation of osteoblastogenesis and osteoclastogenesis김범택, 김정현, 박은국, 원예연, 정선용, 정윤석, 최용준
2023Amphiregulin Induces iNOS and COX-2 Expression through NF- κ B and MAPK Signaling in Hepatic Inflammation강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
20232023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association김대중, 김혜진
2023Effect of statin use on head and neck cancer prognosis in a multicenter study using a Common Data Model김철호, 박래웅, 신유섭, 장전엽, 전자영
2023Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells강엽, 김혜진, 이관우, 전자영, 최성이
2023Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension김혜진
2022Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study김대중, 김은진, 정윤정, 최영화, 하경화, 허중연
2022Gene Network Analysis for Osteoporosis, Sarcopenia, Diabetes, and Obesity in Human Mesenchymal Stromal Cells정윤석, 최용준
2022Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study김혜진
2022A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus한승진
2022Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations김대중
2022Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022김대중
2022Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study김대중, 하경화
2022Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9)김대중
2022The Positive Association between Muscle Mass and Bone Status Is Conserved in Men with Diabetes: A Retrospective Cross-Sectional and Longitudinal Study김대중, 김혜진, 정윤석, 최용준, 한승진
1 2 3 4 5 6 7 8 9 10 11 13

Browse